Furthermore, patients in the metformin group had a lower prevalence of comorbidities (e.g., hypertension, chronic kidney disease, and stroke), were less likely to be prescribed such medications as glinides, alpha glucosidase inhibitors or sulfonylurea, and steroids, and were more likely to be prescribed a statin (P < 0.05). The gene discussed is GAA; the disease is chronic kidney disease.